Products

Erlonat 150mg (Erlotinib) Capsule – Global Supplier & Exporter | Ernest Oncology Erlonat 150mg Erlotinib Capsules – Targeted Therapy for Lung & Pancreatic Cancer Erlonat 150mg Capsule (Erlotinib) is an advanced targeted anti-cancer medication used for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. Erlotinib belongs to the class of EGFR tyrosine kinase inhibitors (TKIs) that block specific signals responsible for cancer cell growth and tumor progression. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Erlonat 150mg (Erlotinib) Capsules to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global medical procurement companies across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Erlonat 150mg (Erlotinib) Capsule? Erlonat 150 mg contains Erlotinib Hydrochloride, a targeted therapy that blocks the epidermal growth factor receptor (EGFR) found on the surface of cancer cells. EGFR plays a critical role in cancer cell survival and growth. By inhibiting this receptor, Erlotinib helps slow down the growth and spread of cancer cells. Erlotinib is widely used in modern oncology treatment protocols for EGFR-positive cancers. Mechanism of Action Erlotinib works by inhibiting the EGFR tyrosine kinase enzyme, which is responsible for activating cancer growth pathways. Its pharmacological effects include: • Blocking EGFR signaling pathways • Preventing cancer cell multiplication • Slowing tumor growth and metastasis • Promoting apoptosis (programmed cancer cell death) This targeted therapy approach makes Erlotinib an important medicine in precision oncology treatment. Medical Uses of Erlonat 150mg Capsule Doctors prescribe Erlonat (Erlotinib) for several cancer treatment protocols: Non-Small Cell Lung Cancer (NSCLC) Erlotinib is widely used for patients with advanced or metastatic non-small cell lung cancer, particularly those with EGFR gene mutations. Pancreatic Cancer Often used in combination with Gemcitabine chemotherapy to treat advanced pancreatic cancer. Targeted Therapy for EGFR-Positive Tumors Patients with EGFR-mutated tumors benefit significantly from Erlotinib therapy. Benefits of Erlonat 150mg (Erlotinib) Capsule • Advanced targeted therapy for lung cancer • Blocks EGFR signaling responsible for tumor growth • Helps control progression of metastatic cancer • Oral treatment option for patient convenience • Recommended in global oncology treatment guidelines Product Information Product Name: Erlonat Capsule Generic Name: Erlotinib Hydrochloride Strength: 150 mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer / EGFR Tyrosine Kinase Inhibitor Indication: Non-Small Cell Lung Cancer, Pancreatic Cancer Prescription: Required Global Demand for Erlotinib Capsules The increasing global incidence of lung cancer and pancreatic cancer has significantly increased demand for Erlotinib targeted therapy medicines. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Erlotinib capsules from trusted pharmaceutical exporters in India such as Ernest Oncology. Erlonat 150mg Capsule Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Capegard 500mg Tablet (Capecitabine) – Global Supplier & Exporter | Ernest Oncology Capegard 500mg Tablet Capegard 500mg Tablet contains Capecitabine, an oral chemotherapy medicine used in the treatment of several cancers including breast cancer, colorectal cancer, and gastric cancer. It belongs to the class of antimetabolite chemotherapy medicines and works by slowing or stopping the growth of cancer cells. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Capegard 500mg tablets to hospitals, oncology clinics, pharmaceutical distributors, and international wholesalers worldwide. What is Capegard 500mg Tablet? Capegard 500mg Tablet is an oral chemotherapy drug that is converted in the body into 5-fluorouracil (5-FU), a powerful anti-cancer agent. It interferes with DNA synthesis in cancer cells, preventing them from multiplying and spreading. Because it is taken orally, Capecitabine provides a convenient alternative to certain intravenous chemotherapy treatments. Mechanism of Action Capecitabine works as a prodrug of 5-fluorouracil (5-FU). Its mechanism includes: • Conversion into active 5-FU in tumor tissues • Inhibition of DNA synthesis in cancer cells • Blocking tumor cell growth and replication • Slowing progression of cancer This targeted activation helps increase effectiveness while reducing systemic toxicity. Indications Capegard 500mg Tablet is used for the treatment of: • Breast Cancer • Colorectal Cancer • Metastatic Colorectal Cancer • Gastric (Stomach) Cancer It may be used alone or in combination with other chemotherapy medicines. Dosage & Administration Typical dosage guidelines: • Dosage depends on body surface area and medical condition • Usually taken twice daily after meals • Tablets should be swallowed with water Treatment should be taken under the supervision of an oncologist. Key Benefits of Capegard 500mg Tablet ✔ Effective oral chemotherapy treatment ✔ Helps control tumor growth ✔ Convenient alternative to intravenous chemotherapy ✔ Used in combination cancer therapy ✔ Improves cancer treatment outcomes Possible Side Effects Some patients may experience: • Nausea • Vomiting • Diarrhea • Fatigue • Hand-foot syndrome • Loss of appetite Patients should be monitored regularly during treatment. Product Specifications Product Name: Capegard Generic Name: Capecitabine Strength: 500 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Antimetabolite Chemotherapy Packaging: Bottle / Blister Storage: Store below 25°C Ernest Oncology supplies Capegard 500mg tablets worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Website www.oncologymedicinesupplier.com www.ernestvision.com www.ernestempex.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Erlonat 100mg (Erlotinib) Tablet – Global Supplier & Exporter | Ernest Oncology Erlonat 100mg Erlotinib Tablets – Targeted Therapy for Lung & Pancreatic Cancer Erlonat 100mg Tablet (Erlotinib) is a widely used targeted anti-cancer medication prescribed for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. Erlotinib belongs to a class of medicines known as EGFR tyrosine kinase inhibitors, which block signals that promote cancer cell growth and multiplication. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Erlonat 100mg (Erlotinib) Tablets to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and global healthcare procurement companies across major healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Erlonat 100mg (Erlotinib) Tablet? Erlonat 100mg contains Erlotinib Hydrochloride, a targeted therapy designed to block the epidermal growth factor receptor (EGFR) pathway. EGFR is a protein found on cancer cells that stimulates tumor growth. By blocking this receptor, Erlotinib helps slow down or stop the growth of cancer cells. Erlotinib therapy is widely used in modern oncology treatment protocols worldwide. Mechanism of Action Erlotinib works by inhibiting the EGFR tyrosine kinase enzyme, which plays an important role in cancer cell growth. Its pharmacological actions include: • Blocking EGFR signaling pathways • Preventing cancer cell proliferation • Reducing tumor growth and spread • Inducing cancer cell death This targeted mechanism allows Erlotinib to treat cancer more precisely compared with traditional chemotherapy. Medical Uses of Erlonat 100mg Tablet Doctors prescribe Erlonat (Erlotinib) for several cancer treatments: Non-Small Cell Lung Cancer (NSCLC) Erlotinib is widely used for advanced or metastatic non-small cell lung cancer, especially in patients with EGFR mutations. Pancreatic Cancer Often prescribed in combination with Gemcitabine for treating advanced pancreatic cancer. Targeted Therapy for EGFR-Positive Tumors Used when cancer cells show EGFR genetic mutations, making them sensitive to EGFR inhibitors. Benefits of Erlonat 100mg (Erlotinib) Tablet • Advanced targeted therapy for lung cancer • Blocks EGFR signaling responsible for tumor growth • Effective treatment for EGFR-positive tumors • Oral tablet form for convenient administration • Widely recommended in international oncology treatment guidelines Product Information Product Name: Erlonat Tablet Generic Name: Erlotinib Hydrochloride Strength: 100 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / EGFR Tyrosine Kinase Inhibitor Indication: Non-Small Cell Lung Cancer, Pancreatic Cancer Prescription: Required Global Demand for Erlotinib Tablets The rising global incidence of lung cancer and pancreatic cancer has increased demand for Erlotinib targeted therapy medicines. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Erlotinib tablets from trusted pharmaceutical exporters in India such as Ernest Oncology. Erlonat 100mg Tablet Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymedicinesupplier.com www.ernestvision.com www.ernestempex.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

Clokeran 5mg (Chlorambucil) Tablet – Global Supplier & Exporter | Ernest Oncology Clokeran 5mg Chlorambucil Tablets – Chemotherapy Medicine for Leukemia & Lymphoma Clokeran 5mg Tablet (Chlorambucil) is a well-known oral chemotherapy medicine used for the treatment of several types of blood cancers, including chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, and non-Hodgkin lymphoma. Chlorambucil belongs to the class of alkylating agents, which work by damaging the DNA of cancer cells and preventing them from growing and multiplying. Ernest Oncology, a reliable pharmaceutical exporter from India, supplies Clokeran 5mg (Chlorambucil) Tablets to oncology hospitals, cancer treatment centers, pharmaceutical wholesalers, and global healthcare procurement companies across major medical markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. What is Clokeran 5mg (Chlorambucil) Tablet? Clokeran 5mg contains Chlorambucil, a widely used chemotherapy drug that interferes with the DNA replication process of cancer cells. This prevents the abnormal cells from dividing and eventually leads to cancer cell death. Chlorambucil has been used for many years in oncology and remains an important treatment option for certain leukemia and lymphoma patients. Mechanism of Action Chlorambucil works by alkylating DNA strands in cancer cells, disrupting their ability to replicate. Its pharmacological actions include: • Cross-linking cancer cell DNA • Preventing replication of malignant cells • Blocking tumor cell proliferation • Inducing apoptosis (programmed cancer cell death) Through these mechanisms, Chlorambucil helps control the growth of leukemia and lymphoma cells. Medical Uses of Clokeran 5mg Tablet Doctors prescribe Clokeran (Chlorambucil) for several cancer treatment protocols: Chronic Lymphocytic Leukemia (CLL) Used as a treatment option for patients diagnosed with CLL, a slow-growing blood cancer. Hodgkin Lymphoma Sometimes used in chemotherapy regimens for Hodgkin lymphoma. Non-Hodgkin Lymphoma Effective for certain types of low-grade non-Hodgkin lymphoma. Other Hematologic Disorders Occasionally prescribed for specific bone marrow disorders and autoimmune conditions. Benefits of Clokeran 5mg (Chlorambucil) Tablet • Effective chemotherapy for leukemia and lymphoma • Oral tablet form for convenient treatment • Long history of use in oncology therapy • Helps control cancer cell proliferation • Recommended in certain international oncology protocols Product Information Product Name: Clokeran Tablet Generic Name: Chlorambucil Strength: 5 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Alkylating Agent Indication: Leukemia, Hodgkin lymphoma, Non-Hodgkin lymphoma Prescription: Required Global Demand for Chlorambucil Tablets The rising incidence of blood cancers such as leukemia and lymphoma worldwide has increased demand for Chlorambucil chemotherapy medicines. Healthcare providers and pharmaceutical distributors in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica frequently import Chlorambucil tablets from trusted pharmaceutical exporters in India, such as Ernest Oncology. Clokeran 5mg Tablet Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies medicines to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical wholesalers • Medical distributors • Government healthcare tenders • International NGOs and procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global distribution network covering 100+ countries • GMP-compliant medicines • Competitive bulk pricing for distributors • Secure international packaging • Fast export logistics and worldwide delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation, including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance for pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensupplier.com www.ernestvision.com www.ernestempex.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383s.

Lenalid 25mg Capsules (Lenalidomide) – Global Supplier & Exporter | Ernest Oncology Lenalid 25mg Capsules Lenalid 25mg Capsules contain Lenalidomide, an immunomodulatory anti-cancer medicine used in the treatment of multiple myeloma and certain blood disorders. The medicine works by strengthening the immune system and preventing the growth of abnormal cancer cells. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Lenalid 25mg capsules to hospitals, oncology centers, pharmaceutical distributors, and international wholesalers worldwide. What are Lenalid 25mg Capsules? Lenalid 25mg Capsules are used in the treatment of multiple myeloma, a cancer affecting plasma cells in the bone marrow. The active ingredient Lenalidomide belongs to the class of immunomodulatory drugs (IMiDs) that help the body’s immune system detect and destroy cancer cells. The medicine also prevents the formation of new blood vessels that tumors need for growth. Mechanism of Action Lenalidomide works through multiple mechanisms to fight cancer: • Stimulates immune cells to attack cancer cells • Inhibits growth and multiplication of tumor cells • Blocks formation of blood vessels supplying tumors • Promotes apoptosis (programmed death) of cancer cells These actions help slow the progression of multiple myeloma. Indications Lenalid 25mg Capsules are used for the treatment of: • Multiple Myeloma • Myelodysplastic Syndrome (MDS) • Mantle Cell Lymphoma (MCL) • Follicular Lymphoma It is commonly prescribed in combination with dexamethasone or other chemotherapy medicines. Dosage & Administration Typical dosage guidelines: • 25 mg once daily • Taken for 21 days followed by 7 days rest in a 28-day cycle • Capsules should be swallowed whole with water Treatment must be taken under the supervision of an oncologist. Key Benefits of Lenalid 25mg Capsules ✔ Effective treatment for multiple myeloma ✔ Strengthens the immune system against cancer ✔ Helps slow tumor growth ✔ Prevents blood vessel formation in tumors ✔ Convenient oral capsule therapy Possible Side Effects Some patients may experience: • Fatigue • Low blood cell counts • Nausea • Constipation • Infections • Skin rash Patients should be monitored regularly during treatment. Product Specifications Product Name: Lenalid Generic Name: Lenalidomide Strength: 25 mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer / Immunomodulatory Agent Packaging: Bottle / Blister Storage: Store below 25°C Ernest Oncology supplies Lenalid 25mg capsules worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestvision.com www.ernestempex.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Bdenza 40mg Capsules (Enzalutamide) – Global Supplier & Exporter | Ernest Oncology Bdenza 40mg Capsules Bdenza 40mg Capsules contain Enzalutamide, a targeted anti-cancer medicine used for the treatment of advanced prostate cancer. This medication belongs to the class of androgen receptor inhibitors, which block the effects of male hormones (androgens) that promote the growth of prostate cancer cells. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Bdenza 40mg capsules to hospitals, oncology clinics, pharmaceutical distributors, and international wholesalers worldwide. What are Bdenza 40mg Capsules? Bdenza 40mg Capsules are used in the treatment of metastatic and non-metastatic prostate cancer. The medicine works by preventing androgens from binding to androgen receptors, thereby inhibiting cancer cell growth. By blocking androgen signaling, Bdenza helps slow tumor progression and improve survival outcomes in prostate cancer patients. Mechanism of Action Enzalutamide works by inhibiting the androgen receptor signaling pathway. Its mechanism includes: • Blocking androgen receptor binding • Preventing androgen receptor activation • Inhibiting nuclear translocation of androgen receptors • Stopping androgen-driven tumor growth This helps reduce cancer cell growth and slow disease progression. Indications Bdenza 40mg Capsules are used for the treatment of: • Metastatic Castration-Resistant Prostate Cancer (mCRPC) • Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) It may be used alone or in combination with androgen deprivation therapy. Dosage & Administration Typical dosage guidelines: • 160 mg once daily (4 capsules of 40 mg) • Taken with or without food • Capsules should be swallowed whole with water Treatment must be taken under the supervision of an oncologist. Key Benefits of Bdenza 40mg Capsules ✔ Advanced targeted therapy for prostate cancer ✔ Helps slow tumor growth ✔ Improves survival in advanced prostate cancer ✔ Convenient oral capsule treatment ✔ Effective androgen receptor inhibitor therapy Possible Side Effects Some patients may experience: • Fatigue • High blood pressure • Headache • Hot flashes • Weakness • Joint pain Patients should be monitored regularly during treatment. Product Specifications Product Name: Bdenza Generic Name: Enzalutamide Strength: 40 mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer / Androgen Receptor Inhibitor Packaging: Bottle / Blister Storage: Store below 25°C Ernest Oncology supplies Bdenza 40mg capsules worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Jemperli 500mg Injection (Dostarlimab) – Global Supplier & Exporter | Ernest Oncology Jemperli 500mg Injection Jemperli 500mg Injection contains Dostarlimab, an advanced immunotherapy medicine used in the treatment of certain types of endometrial cancer and other solid tumors. It belongs to the class of PD-1 immune checkpoint inhibitors, which help the immune system recognize and attack cancer cells. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Jemperli 500mg injections to hospitals, oncology centers, pharmaceutical distributors, and international wholesalers worldwide. What is Jemperli 500mg Injection? Jemperli is a monoclonal antibody immunotherapy designed to treat cancers with mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) characteristics. The medicine works by activating the immune system to detect and destroy cancer cells. This targeted immunotherapy helps improve treatment outcomes for patients with advanced cancers. Mechanism of Action Dostarlimab works by blocking the Programmed Death-1 (PD-1) receptor found on immune cells. Its mechanism includes: • Blocking the PD-1 immune checkpoint pathway • Enhancing immune system response against cancer cells • Restoring the body’s ability to detect and destroy tumor cells • Slowing cancer growth and progression Indications Jemperli 500mg Injection is used for the treatment of: • Endometrial Cancer with dMMR or MSI-H • Advanced or Recurrent Endometrial Cancer • Certain solid tumors with mismatch repair deficiency It is generally used when cancer has progressed after other treatments. Dosage & Administration Typical dosage guidelines: • 500 mg administered intravenously every 3 weeks • Later adjusted to 1000 mg every 6 weeks depending on treatment protocol • Given as an IV infusion in hospital or clinical settings Treatment should be administered under the supervision of an oncologist. Key Benefits of Jemperli 500mg Injection ✔ Advanced immunotherapy for cancer treatment ✔ Activates the immune system to fight cancer ✔ Effective for dMMR / MSI-H tumors ✔ Helps control tumor progression ✔ Targeted monoclonal antibody therapy Possible Side Effects Some patients may experience: • Fatigue • Nausea • Diarrhea • Skin rash • Fever • Immune-related reactions Patients should be monitored regularly during treatment. Product Specifications Product Name: Jemperli Generic Name: Dostarlimab Strength: 500 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Immunotherapy / PD-1 Inhibitor Packaging: Vial Storage: Store in refrigerator (2°C – 8°C), do not freeze Ernest Oncology supplies Jemperli 500mg injections worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestvision.com www.ernestempex.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Zoladex 3.6mg Injection (Goserelin Acetate) – Global Supplier & Exporter | Ernest Oncology Zoladex 3.6mg Injection Zoladex 3.6mg Injection contains Goserelin Acetate, a hormone therapy medicine used in the treatment of prostate cancer, breast cancer, endometriosis, and other hormone-related conditions. This medicine belongs to a class known as LHRH (GnRH) agonists, which work by reducing hormone levels in the body. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Zoladex 3.6mg injections to hospitals, oncology clinics, pharmaceutical distributors, and international wholesalers worldwide. What is Zoladex 3.6mg Injection? Zoladex 3.6mg Injection is a long-acting hormonal therapy that works by lowering levels of testosterone in men and estrogen in women. Many cancers depend on these hormones to grow. By reducing hormone production, Zoladex helps slow or stop the growth of hormone-dependent tumors. Mechanism of Action Goserelin acts as a Gonadotropin-Releasing Hormone (GnRH) agonist. Its mechanism includes: • Initially stimulating release of LH and FSH hormones • Subsequently suppressing hormone production • Reducing testosterone and estrogen levels • Slowing hormone-dependent cancer growth Indications Zoladex 3.6mg Injection is used for the treatment of: • Prostate Cancer • Breast Cancer • Endometriosis • Uterine Fibroids • Advanced Hormone-Dependent Cancers It may also be used as adjuvant therapy in certain hormone-sensitive conditions. Dosage & Administration Typical dosage guidelines: • 3.6 mg injection every 28 days • Administered subcutaneously in the abdominal area • Given by a healthcare professional Treatment should be taken under medical supervision. Key Benefits of Zoladex 3.6mg Injection ✔ Effective hormone therapy for cancer treatment ✔ Helps reduce hormone production in the body ✔ Slows growth of hormone-dependent tumors ✔ Long-acting injection therapy ✔ Widely used in prostate and breast cancer management Possible Side Effects Some patients may experience: • Hot flashes • Mood changes • Decreased libido • Bone thinning • Injection site reactions • Headache Patients should be monitored regularly during treatment. Product Specifications Product Name: Zoladex Generic Name: Goserelin Acetate Strength: 3.6 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / LHRH (GnRH) Agonist Packaging: Prefilled Syringe / Implant Storage: Store below 25°C Ernest Oncology supplies Zoladex 3.6mg injections worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Website www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383 This mechanism helps control hormone-sensitive cancers.

Ramiven 150 Tablet (Rucaparib) – Global Supplier & Exporter | Ernest Oncology Ramiven 150 Tablet Ramiven 150 Tablet contains Rucaparib, a targeted anti-cancer medication used in the treatment of ovarian cancer and certain types of prostate cancer. This medicine belongs to a class of drugs known as PARP inhibitors, which work by preventing cancer cells from repairing their damaged DNA, leading to cancer cell death. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Ramiven 150 tablets to hospitals, oncology centers, pharmaceutical distributors, and international wholesalers worldwide. What is Ramiven 150 Tablet? Ramiven 150 Tablet is a targeted therapy medicine designed to treat cancers that have BRCA gene mutations or defects in DNA repair mechanisms. The medicine blocks enzymes known as Poly (ADP-ribose) polymerase (PARP) that help cancer cells repair DNA damage. By blocking PARP enzymes, Ramiven causes DNA damage accumulation in cancer cells, ultimately leading to their destruction. Mechanism of Action Rucaparib works by inhibiting PARP enzymes (PARP-1, PARP-2, PARP-3) involved in DNA repair. This mechanism: • Prevents repair of damaged DNA in cancer cells • Causes accumulation of DNA damage • Leads to cancer cell death • Slows tumor growth and disease progression Indications Ramiven 150 Tablet is used for the treatment of: • Ovarian Cancer • Fallopian Tube Cancer • Primary Peritoneal Cancer • Metastatic Castration-Resistant Prostate Cancer (mCRPC) with BRCA mutation It may be used as maintenance therapy or treatment for advanced cancers. Dosage & Administration Typical dosage guidelines: • 600 mg twice daily (usually four 150 mg tablets per dose) • Taken with or without food • Tablets should be swallowed whole with water Treatment should always be taken under the supervision of a qualified oncologist. Key Benefits of Ramiven 150 Tablet ✔ Advanced targeted PARP inhibitor therapy ✔ Helps slow cancer progression ✔ Effective in BRCA-mutated cancers ✔ Convenient oral tablet treatment ✔ Improves progression-free survival in ovarian cancer Possible Side Effects Some patients may experience: • Nausea • Fatigue • Anemia • Vomiting • Loss of appetite • Abdominal pain Patients should be regularly monitored during treatment. Product Specifications Product Name: Ramiven Generic Name: Rucaparib Strength: 150 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / PARP Inhibitor Packaging: Bottle / Blister Storage: Store below 25°C We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestvision.com www.ernestempex.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Arimidex 1mg Tablet (Anastrozole) – Global Supplier & Exporter | Ernest Oncology Arimidex 1mg Tablet Arimidex 1mg Tablet contains Anastrozole, a hormonal anti-cancer medicine used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It belongs to a class of medicines known as aromatase inhibitors, which help reduce estrogen levels in the body and slow the growth of certain breast cancer cells. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Arimidex 1mg tablets to hospitals, oncology clinics, pharmaceutical distributors, and international wholesalers worldwide. What is Arimidex 1mg Tablet? Arimidex is a hormonal therapy medicine used to treat breast cancer in women who have gone through menopause. The medicine works by lowering estrogen production, a hormone that can promote the growth of certain types of breast cancer. By reducing estrogen levels, Arimidex helps slow or stop the growth of hormone-sensitive breast cancer cells. Mechanism of Action Anastrozole works by blocking the enzyme aromatase, which is responsible for converting androgens into estrogen in postmenopausal women. This mechanism helps: • Reduce estrogen levels in the body • Prevent hormone-dependent tumor growth • Slow the progression of breast cancer • Improve treatment outcomes in hormone-receptor positive cancers Indications Arimidex 1mg Tablet is used for the treatment of: • Early Breast Cancer in Postmenopausal Women • Advanced or Metastatic Breast Cancer • Hormone Receptor-Positive Breast Cancer It may be used as initial therapy or after treatment with tamoxifen. Dosage & Administration Typical dosage guidelines: • 1 mg once daily • Taken with or without food • Tablets should be swallowed whole with water Treatment should always be taken under medical supervision. Key Benefits of Arimidex 1mg Tablet ✔ Effective hormonal therapy for breast cancer ✔ Reduces estrogen production in the body ✔ Helps slow tumor growth ✔ Convenient once-daily oral tablet ✔ Improves outcomes in hormone-sensitive breast cancer Possible Side Effects Some patients may experience: • Hot flashes • Joint pain • Weakness or fatigue • Nausea • Bone thinning (osteoporosis) • Headache Regular medical monitoring is recommended during treatment. Product Specifications Product Name: Arimidex Generic Name: Anastrozole Strength: 1 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Aromatase Inhibitor Packaging: Bottle / Blister Storage: Store below 25°C Ernest Oncology supplies Arimidex 1mg tablets worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Website www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Xtandi 40mg Capsules (Enzalutamide) – Global Supplier & Exporter | Ernest Oncology Xtandi 40mg Capsules Xtandi 40mg Capsules contain Enzalutamide, a targeted anti-cancer medicine used in the treatment of advanced prostate cancer. This medication belongs to a class of drugs known as androgen receptor inhibitors, which help slow the growth and spread of prostate cancer cells. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Xtandi 40mg capsules to hospitals, oncology clinics, pharmaceutical distributors, and international wholesalers worldwide. What are Xtandi 40mg Capsules? Xtandi is an oral anti-cancer medicine used for the treatment of metastatic and non-metastatic prostate cancer. It works by blocking the effect of androgens (male hormones such as testosterone) that stimulate the growth of prostate cancer cells. By inhibiting androgen receptor activity, Xtandi helps control cancer progression and improve survival outcomes in patients with advanced prostate cancer. Mechanism of Action Enzalutamide works by targeting androgen receptor signaling pathways. It works by: • Blocking androgen receptor binding • Preventing androgen receptor activation • Inhibiting nuclear translocation of androgen receptors • Stopping androgen-driven cancer cell growth This mechanism helps slow tumor progression and reduce cancer spread. Indications Xtandi 40mg Capsules are used for the treatment of: • Metastatic Castration-Resistant Prostate Cancer (mCRPC) • Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) • Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Xtandi may be used alone or in combination with androgen deprivation therapy. Dosage & Administration Typical dosage guidelines: • 160 mg once daily (4 capsules of 40 mg) • Taken with or without food • Capsules should be swallowed whole with water Treatment should always be taken under the supervision of a qualified oncologist. Key Benefits of Xtandi 40mg Capsules ✔ Advanced targeted therapy for prostate cancer ✔ Helps delay disease progression ✔ Improves survival in advanced prostate cancer ✔ Oral capsule therapy for convenient administration ✔ Effective androgen receptor inhibitor Possible Side Effects Some patients may experience: • Fatigue • High blood pressure • Hot flashes • Headache • Weakness • Joint pain Patients should undergo regular monitoring during treatment. Product Specifications Product Name: Xtandi Generic Name: Enzalutamide Strength: 40 mg Dosage Form: Capsule Therapeutic Class: Anti-Cancer / Androgen Receptor Inhibitor Packaging: Bottle / Blister Storage: Store below 25°C Ernest Oncology supplies Xtandi 40mg capsules worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Website www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Emai exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Imatib 100mg Tablet (Imatinib Mesylate) – Global Supplier & Exporter | Ernest Oncology Imatib 100mg Tablet Imatib 100mg Tablet contains Imatinib Mesylate, a targeted anti-cancer medication used in the treatment of several cancers including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). This medicine belongs to the class of tyrosine kinase inhibitors (TKIs) and works by blocking abnormal proteins that promote cancer cell growth. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Imatib 100mg tablets to hospitals, oncology clinics, pharmaceutical distributors, and international wholesalers worldwide. What is Imatib 100mg Tablet? Imatib 100mg Tablet is a targeted therapy medicine used to treat specific cancers caused by abnormal cell signaling. The active ingredient Imatinib blocks the activity of certain enzymes known as tyrosine kinases, which play a key role in cancer cell growth and proliferation. By inhibiting these enzymes, the medication helps slow or stop the growth of cancer cells. Mechanism of Action Imatinib works by inhibiting abnormal tyrosine kinase enzymes responsible for cancer development. It targets: • BCR-ABL tyrosine kinase in leukemia cells • KIT receptor in gastrointestinal stromal tumors • PDGFR (platelet-derived growth factor receptor) This mechanism helps: • Stop cancer cell multiplication • Prevent tumor growth • Improve treatment outcomes in targeted cancers Indications Imatib 100mg Tablet is used in the treatment of: • Chronic Myeloid Leukemia (CML) • Acute Lymphoblastic Leukemia (ALL) • Gastrointestinal Stromal Tumors (GIST) • Myelodysplastic/Myeloproliferative Diseases (MDS/MPD) • Hypereosinophilic Syndrome (HES) Dosage & Administration Typical dosage guidelines: • Dose varies depending on the disease condition • Usually taken once or twice daily with food • Tablets should be swallowed whole with water Treatment should always be taken under medical supervision. Key Benefits of Imatib 100mg Tablet ✔ Targeted cancer therapy ✔ Effective treatment for leukemia and GIST ✔ Blocks abnormal cancer cell signaling ✔ Helps control tumor growth ✔ Oral tablet therapy for convenient treatment Possible Side Effects Some patients may experience: • Nausea • Vomiting • Fatigue • Muscle cramps • Fluid retention • Skin rash Regular monitoring by healthcare professionals is recommended. Product Specifications Product Name: Imatib Generic Name: Imatinib Mesylate Strength: 100 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Tyrosine Kinase Inhibitor Packaging: Bottle / Blister Storage: Store below 25°C We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383